ovel Treatment of Phobias in Children and Teenagers

Phase 2

Recruiting

• Conditions: Pediatric Specific Phobia Disorder; Mental Health - Anxiety

• Registration Number: ACTRN12612000420842
• Lead Sponsor: Dr Allison Waters

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-04-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1. Primary Diagnosis of any Anxiety Disorder
2. DSM-IV-TR Specific Phobia Diagnosis
3. If taking a selective-serotonin reuptake inhibitor (SSRI) medication, dose must be stable for one-month prior to study entry and remain unchanged.

Exclusion Criteria

Exclusion criteria for participants include:
1. Organic mental disorder
2. Other medications that are contraindicated with D-Cycloserine (DCS)
3. Pregnancy (this will be screened for and if sexually active be required to use birth control)
4. Psychosis
5. Pervasive developmental disorder
6. History of seizure
7. History of other serious medical condition that can be contraindicated with DCS (i.e. cardiovascular, liver, kidney, respiratory etc.)
8. Serious suicidal risk
9. Concurrent psychotherapy
10. Current diagnosis of tuberculosis (TB)
11. Currently taking medication that lowers seizure threshold (ie., clozapine)
12. Impaired intelligence (IQ; likely < 70)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety Disorders Interview Schedule (ADIS) - Child/ Parent Versions[Pre-Treatment, Post-Treatment, 1 month Follow Up, 3 Month Follow Up and 12 Month Follow up.];Childrens Global Assessment Scale (CGAS) - This a global measure of level of functioning in children and adolscents.[Pre-Treatment, Post-Treatment, 1 month Follow Up, 3 Month Follow Up and 12 Month Follow up.]

Secondary Outcome Measures

Name	Time	Method
Fear Survey Schedule for Children Revised[Pre-Treatment, Post-Treatment,1 month Follow Up, 3 Month Follow Up and 12 Month Follow up.];Spence Children's Anxiety Scale[Pre-Treatment, Post-Treatment, 1 month Follow Up, 3 Month Follow Up and 12 Month Follow up.]